Krka Logo

Krka

An international generic pharmaceutical company developing human and animal health products.

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto

Description

Krka is an international generic pharmaceutical company engaged in the development, production, marketing, and sales of human and animal health products. The company's core business is focused on generic prescription pharmaceuticals, which it markets under its own brands. Its product portfolio is complemented by a range of non-prescription products and a comprehensive line of animal health products. With a history spanning over 70 years, Krka is committed to providing high-quality, effective, and safe products to a global market, aiming to contribute to a better quality of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-11-30 08:21
Financial Calendar 2022
English 119.9 KB
2021-11-29 08:30
Acquisition of treasury shares
English 2.3 KB
2021-11-29 08:30
Pridobivanje lastnih delnic
Slovene 2.2 KB
2021-11-19 08:30
Press Release
English 248.4 KB
2021-11-19 08:30
The Krka Group and Krka, d.d. Unaudited Quarterly Report, 1 January to 30 Septe…
English 1.7 MB
2021-11-19 08:30
Sporočilo za javnost
Slovene 241.2 KB
2021-11-19 08:30
Nerevidirano poročilo o poslovanju skupine Krka in družbe Krka v obdobju januar…
Slovene 1.7 MB
2021-11-18 08:16
Press Release
English 248.4 KB
2021-11-18 08:16
Unaudited interim report of the Krka Group and Krka, d. d., Novo mesto for the …
English 1.7 MB
2021-10-12 08:30
Acquisition of treasury shares
English 2.2 KB
2021-09-28 08:30
Obvestilo o spremembi deleža lastnih delnic
Slovene 125.5 KB
2021-09-13 08:30
Pridobivanje lastnih delnic
Slovene 2.1 KB
2021-07-30 08:30
Press Release
English 248.5 KB
2021-07-30 08:30
2021 Unaudited Semi-Annual Report of the Krka group and Krka, d. d., Novo mesto
English 1.6 MB
2021-07-30 08:30
Sporočilo za javnost
Slovene 236.5 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Krka

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Arcus Biosciences, Inc. Logo
A clinical-stage biopharmaceutical company developing combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes treatments for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharmaceutical company developing medicines for cardiorenal and gastrointestinal diseases.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharmaceutical company enhancing medicines with its proprietary formulation technology.
United Kingdom
AREC
argenx SE Logo
Develops and commercializes antibody-based therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Develops bacteriophage therapeutics for antibiotic-resistant bacterial infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets in vitro diagnostic (IVD) tests for oncology and bacteriology.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
Clinical-stage biopharma developing oncology drugs for difficult-to-treat diseases.
United States of America
AVBP
ARROWHEAD PHARMACEUTICALS, INC. Logo
Biotechnology company developing RNAi therapies to treat intractable diseases.
United States of America
ARWR
ARS Pharmaceuticals, Inc. Logo
Develops and commercializes needle-free products for administering therapies.
United States of America
SPRY

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.